Another study about doctor-patient divide

Share this article:

Surprise: doctors and patients don't communicate well. On Tuesday, Novo Nordisk released results from its "Diabetes, Attitudes, Wishes and Needs 2 Study" at the World Diabetes Congress of the International Diabetes Federation in Melbourne, Australia. Its data gurus found that only 29% of polled diabetes patients said their healthcare teams asked their opinion on treatment regimens.

This global number is of note not only because of its geographic scope, but because so many studies indicate that communication is a key to medication adherence. Some items that could come up in doctor-patient adherence discussions: cost, complexity and access, all of which can have an impact on a patient's ability and willingness to stick with a prescribed regimen.

Further emphasizing the doctor-patient divide: the poll also showed that 84% of polled healthcare professionals “said it would be helpful if their patients prepared questions in advance of the consultation.”

Missing is whether doctors expect patients to broach the subject or whether they ask—or feel they ask—patients for their perspective or a list of questions.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.